We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-1.83%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$696M
AUM Growth
-$17.3M
Cap. Flow
-$537K
Cap. Flow %
-0.08%
Top 10 Hldgs %
15.81%
Holding
288
New
40
Increased
95
Reduced
57
Closed
17

Top Buys

Rank Stock Value
1
FRSH icon
Freshworks
FRSH
+$10.8M
2
JBL icon
Jabil
JBL
+$4.39M
3
GSK icon
GSK
GSK
+$4.1M
4
NOV icon
NOV
NOV
+$3.97M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$3.76M

Sector Composition

Rank Sector Weight
1 Technology 31.67%
2 Industrials 12.69%
3 Healthcare 11.3%
4 Energy 7.93%
5 Financials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTI icon
101
TETRA Technologies
TTI
$1.23B
$3.07M 0.44%
887,878
+109,509
+14% +$437K
OSIS icon
102
OSI Systems
OSIS
$3.57B
$2.89M 0.41%
20,991
+1,046
+5% +$144K
UUUU icon
103
Energy Fuels
UUUU
$2.82B
$2.88M 0.41%
475,563
+22,127
+5% +$135K
SCI icon
104
Service Corp International
SCI
$11.4B
$2.77M 0.4%
38,950
+2,674
+7% +$190K
SNX icon
105
TD Synnex
SNX
$19.4B
$2.77M 0.4%
23,985
+2,241
+10% +$274K
DOW icon
106
Dow Inc
DOW
$21.6B
$2.76M 0.4%
52,036
+2,322
+5% +$133K
AVGO icon
107
Broadcom
AVGO
$1.82T
$2.3M 0.33%
14,350
+1,140
+9% +$160K
JPM icon
108
JPMorgan Chase
JPM
$939B
$2.21M 0.32%
10,936
+919
+9% +$180K
AMZN icon
109
Amazon
AMZN
$2.5T
$1.94M 0.28%
10,044
+930
+10% +$171K
PFE icon
110
Pfizer
PFE
$140B
$1.47M 0.21%
52,430
+2,000
+4% +$55.1K
HUBS icon
111
HubSpot
HUBS
$10.5B
$1.24M 0.18%
2,109
-375
-15% -$230K
SNPS icon
112
Synopsys
SNPS
$71.5B
$1.19M 0.17%
1,999
INFY icon
113
Infosys
INFY
$45B
$1.12M 0.16%
+60,000
New +$1.04M
ASML icon
114
ASML
ASML
$675B
$1.08M 0.16%
4,836
+179
+4% +$172K
IWF icon
115
iShares Russell 1000 Growth ETF
IWF
$122B
$967K 0.14%
10,608
O icon
116
Realty Income
O
$61.2B
$966K 0.14%
18,285
ABT icon
117
Abbott
ABT
$180B
$941K 0.14%
9,052
-1,013
-10% -$107K
META icon
118
Meta Platforms (Facebook)
META
$1.51T
$846K 0.12%
1,678
+352
+27% +$171K
DCBO
119
Docebo
DCBO
$492M
$843K 0.12%
+21,819
New +$896K
DT icon
120
Dynatrace
DT
$12.1B
$842K 0.12%
18,826
-3,242
-15% -$149K
NCNO icon
121
nCino
NCNO
$1.81B
$778K 0.11%
24,747
-2,973
-11% -$92.9K
INTU icon
122
Intuit
INTU
$81.1B
$756K 0.11%
1,151
PG icon
123
Procter & Gamble
PG
$343B
$663K 0.1%
4,018
IWD icon
124
iShares Russell 1000 Value ETF
IWD
$82B
$662K 0.1%
3,795
-5
-0.1% -$874
BRZE icon
125
Braze
BRZE
$2.45B
$652K 0.09%
16,787
-2,717
-14% -$108K

Similar funds

Stanley-Laman Group's Q2 2024 Portfolio in Review

As of Q2 2024, Stanley-Laman Group held 288 positions worth $696M, down 2.4% from $713M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q2 2024 filing shows 40 new, 95 increased, 57 reduced and 17 closed positions. Its largest new stake was Freshworks: 719,687 shares worth $9.13M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $11.3M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q2 2024 buy was Freshworks: 719,687 shares worth $9.13M.
  • Stanley-Laman Group added most to GSK in Q2 2024, an estimated $4.1M increase.
  • Stanley-Laman Group's biggest Q2 2024 reduction was Eli Lilly, cutting an estimated $3.55M.
  • Stanley-Laman Group fully exited HashiCorp, Inc. Class A Common Stock in Q2 2024, selling an estimated $11.3M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $696M portfolio in Q2 2024.
  • Stanley-Laman Group opened 40 new positions and closed 17 in Q2 2024.
  • Stanley-Laman Group's portfolio value fell 2.4% quarter-over-quarter to $696M.

Based on Stanley-Laman Group's 13F filing for Q2 2024, filed 18 Jul 2024.